Decreased α-secretase-cleaved amyloid precursor protein as a diagnostic marker for Alzheimer's diseas

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Nature Medicine

• Publication date

  1995-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/nm0895-829
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• A large Swedish family with Alzheimer's disease with a codon 670/671 amyloid precursor protein mutation. A clinical and genealogical investigation.

  1994cited by this paper
• Altered cleavage and secretion of a recombinant β–APP bearing the Swedish familial Alzheimer's disease mutation

  1994cited by this paper
• Decreased levels of soluble amyloid β‐protein precursor are associated with Alzheimer's disease in concordant and discordant monozygous twin pairs

  1994cited by this paper
• An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.

  1994cited by this paper
• Increased β‐amyloid release and levels of amyloid precursor protein (APP) in fibroblast cell lines from family members with the Swedish Alzheimer's disease APP670/671 mutation

  1994cited by this paper
• Amyloid precursor protein mutation causes Alzheimer's disease in a Swedish family.

  1994cited by this paper
• Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation.

  1994cited by this paper
• Release of excess amyloid beta protein from a mutant amyloid beta protein precursor.

  1993cited by this paper
• Physiological production of the β-amyloid protein and the mechanism of Alzheimer's disease

  1993cited by this paper
• Low frequency of the APP 670/671 mutation in familial Alzheimer's disease in Sweden.

  1993cited by this paper
• Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production

  1992cited by this paper
• Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids

  1992cited by this paper
• A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid

  1992cited by this paper
• Decreased levels of soluble amyloid beta-protein precursor in cerebrospinal fluid of live Alzheimer disease patients.

  1992cited by this paper
• Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis–dutch type share a decrease in cerebrospinal fluid levels of amyloid β‐protein precursor

  1992cited by this paper
• Analysis and Quantitation of the β‐Amyloid Precursor Protein in the Cerebrospinal Fluid of Alzheimer's Disease Patients with a Monoclonal Antibody‐Based Immunoassay

  1991cited by this paper
• Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type.

  1990cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

  1984cited by this paper

• Deletion of Murine APP Aggravates Tau and Amyloid Pathologies in the 5xFADXTg30 Alzheimer’s Disease Model

  2025cites this paper
• Recent Advances in Drug Development for Alzheimer’s Disease: A Comprehensive Review

  2025cites this paper
• Lactate increases ADAM10 activity and reduces BACE1 activity in mouse brain

  2024cites this paper
• Comprehensive investigation of multiple targets in the development of newer drugs for the Alzheimer's disease

  2024cites this paper
• Re-Arranging the Puzzle between the Amyloid-Beta and Tau Pathology: An APP-Centric Approach

  2023cites this paper
• Protective Alzheimer ’ s disease-associated APP A673T variant predominantly decreases sAPP β levels in cerebrospinal fluid and 2D/3D cell culture models

  2023cites this paper
• Mechanisms and Functions of Activity-Regulated Cytoskeleton-Associated Protein in Synaptic Plasticity

  2023cites this paper
• Protective Alzheimer's disease-associated APP A673T variant predominantly decreases sAPPβ levels in cerebrospinal fluid and 2D/3D cell culture models.

  2023cites this paper
• BACE1 Overexpression Reduces SH-SY5Y Cell Viability Through a Mechanism Distinct from Amyloid-β Peptide Accumulation: Beta Prime-Mediated Competitive Depletion of sAβPPα

  2022cites this paper
• Rho-associated kinases contribute to the regulation of tau phosphorylation and amyloid metabolism during neuronal plasticity

  2021cites this paper
• Characterization of Alzheimer's disease‐like neuropathology in Duchenne's muscular dystrophy using the DBA/2J mdx mouse model

  2021cites this paper
• A short peptide from sAPPα binding to BACE1-APP action site rescues Alzheimer-like pathology.

  2021cites this paper
• Deciphering the neuroprotective and neurogenic potential of soluble amyloid precursor protein alpha (sAPPα)

  2020cites this paper
• Substrate-Specific Activation of α-Secretase by 7-Deoxy-Trans-Dihydronarciclasine Increases Non-Amyloidogenic Processing of β-Amyloid Protein Precursor

  2020cites this paper
• Lentivirus-Mediated Expression of Human Secreted Amyloid Precursor Protein-Alpha Promotes Long-Term Induction of Neuroprotective Genes and Pathways in a Mouse Model of Alzheimer’s Disease

  2020cites this paper
• Etude des mécanismes impliquant le facteur de risque génétique FERMT2 dans le métabolisme de l’APP et ses conséquences dans le processus physiopathologique de la maladie d’Alzheimer

  2019cites this paper
• Neuronal function of Alzheimer's protein

  2019cites this paper
• Amyloid Precursor Protein Mediates Neuronal Protection from Rotenone Toxicity

  2019cites this paper
• CSF sAPPα and sAPPβ levels in Alzheimer’s Disease and Multiple Other Neurodegenerative Diseases: A Network Meta-Analysis

  2019cites this paper
• Secreted Amyloid Precursor Protein-Alpha Promotes Arc Protein Synthesis in Hippocampal Neurons

  2019cites this paper
• Trafficking and proteolytic processing of amyloid precursor protein and secretases in Alzheimer's disease development: An up-to-date review.

  2019cites this paper
• Soluble Amyloid Precursor Protein α: Friend or Foe?

  2018cites this paper
• Peptides as Potential Therapeutics for Alzheimer’s Disease

  2018cites this paper
• Neuregulin 1 regulates amyloid precursor protein cell surface expression and non-amyloidogenic processing.

  2018cites this paper
• Therapeutic modulation of Alzheimer’s disease with biological (HUCBS) and pharmacological (LISPRO) approaches

  2018cites this paper
• sAPP&bgr; and sAPP&agr; increase structural complexity and E/I input ratio in primary hippocampal neurons and alter Ca2+ homeostasis and CREB1‐signaling

  2018cites this paper
• Lentivirus-mediated expression of human secreted amyloid precursor protein-alpha prevents development of memory and plasticity deficits in a mouse model of Alzheimer's disease

  2018cites this paper
• A New Perspective in Utilizing MMP-9 as a Therapeutic Target for Alzheimer’s Disease and Type 2 Diabetes Mellitus

  2018cites this paper
• Regulation of Alpha-Secretase ADAM10 In vitro and In vivo: Genetic, Epigenetic, and Protein-Based Mechanisms

  2017cites this paper
• The effects of different familial Alzheimer’s disease mutations on APP processing in vivo

  2017cites this paper
• Amyloid precursor protein reduction enhances the formation of neurofibrillary tangles in a mutant tau transgenic mouse model.

  2017cites this paper
• Therapeutic Potential of Secreted Amyloid Precursor Protein APPsα

  2017cites this paper
• No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF

  2016cites this paper
• Méthodes et composition pharmaceutique pour le traitement de la maladie d'alzheimer

  2016cites this paper
• Complex Treatment of the Patients with Alzheimer?s Disease Using Stem Cell Preparations Including Extracted Fetal Stem Cells

  2016cites this paper
• Direct introduction of R-SO2F moieties into proteins and protein-polymer conjugation using SuFEx chemistry

  2016cites this paper
• Conséquences de la surexpression des formes solubles de l’APP dans les mécanismes de mémoire : application à la maladie d'Alzheimer

  2016cites this paper
• Cerebrospinal Fluid Biomarkers in Familial Forms of Alzheimer's Disease and Frontotemporal Dementia

  2015cites this paper
• Unfolded Protein Response and Macroautophagy in Alzheimer’s, Parkinson’s and Prion Diseases

  2015cites this paper
• Detection of the Alzheimer's disease soluble amyloid precursor protein and modulation of its proteolytic processing

  2014cites this paper
• The multifaceted nature of amyloid precursor protein and its proteolytic fragments: friends and foes

  2014cites this paper
• Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer's 5xFAD mice.

  2014cites this paper
• α-Secretase processing of the Alzheimer amyloid-β precursor protein and its homolog APLP2

  2013cites this paper
• Down’s syndrome, neuroinflammation, and Alzheimer neuropathogenesis

  2013cites this paper
• Biomarkers as Monitors of Drug Effect, Diagnostic Tools and Predictors of Deterioration Rate in Alzheimer’s Disease

  2013cites this paper
• NeuroAiD® (MLC601) and Amyloid Precursor Protein Processing

  2013cites this paper
• Octyl Gallate Markedly Promotes Anti-Amyloidogenic Processing of APP through Estrogen Receptor-Mediated ADAM10 Activation

  2013cites this paper
• Molecular Pathology of Alzheimer's Disease

  2013cites this paper
• Amyloid β precursor protein as a molecular target for amyloid β--induced neuronal degeneration in Alzheimer's disease.

  2013cites this paper
• What’s hAPPening at synapses? The role of amyloid β-protein precursor and β-amyloid in neurological disorders

  2013cites this paper
• Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease.

  2013cites this paper
• The Processing of Amyloid Precursor Protein in the Central Nervous System of Humans and Rhesus Macaques

  2013cites this paper
• The effects of chronic calcium dysregulation on behavioral and pathological features of Alzheimer's disease

  2013cites this paper
• Tol2 gene trap integrations in the zebrafish amyloid precursor protein genes appa and aplp2 reveal accumulation of secreted APP at the embryonic veins

  2012cites this paper
• Evidence supporting the role of calpain in the α-processing of amyloid-β precursor protein.

  2012cites this paper
• Activation of α‐secretase cleavage

  2012cites this paper
• New highly sensitive rodent and human tests for soluble amyloid precursor protein alpha quantification: preclinical and clinical applications in Alzheimer’s disease

  2012cites this paper
• Enhanced neuronal plasticity and elevated endogenous sAPPα levels in mice over‐expressing MMP9

  2012cites this paper
• Pro-inflammatory interleukin-18 increases Alzheimer’s disease-associated amyloid-β production in human neuron-like cells

  2012cites this paper
• Relationship between genetic risk factors and markers for Alzheimer's disease pathology.

  2012cites this paper
• Liposome-incorporated DHA increases neuronal survival by enhancing non-amyloidogenic APP processing.

  2011cites this paper
• The memory enhancing effect of the APP‐derived tripeptide Ac‐rER is mediated through CRMP2

  2011cites this paper
• Bioinformatics Identification of Modules of Transcription Factor Binding Sites in Alzheimer's Disease-Related Genes by In Silico Promoter Analysis and Microarrays

  2011cites this paper
• APP and APLP2 are essential at PNS and CNS synapses for transmission, spatial learning and LTP

  2011cites this paper
• ERK1-independent α-secretase cut of β-amyloid precursor protein via M1 muscarinic receptors and PKCα/ε.

  2011cites this paper
• Biological markers of amyloid beta-related mechanisms in Alzheimer's disease.

  2010cites this paper
• Dual Role of α-Secretase Cleavage in the Regulation of γ-Secretase Activity for Amyloid Production*

  2010cites this paper
• Die Repression der Translation der anti-amyloidogenen Sekretase ADAM10 durch die 5'-untranslatierte Region

  2010cites this paper
• Donepezil and galanin interactions in an animal model of Alzheimer’s disease

  2010cites this paper
• Etazolate improves performance in a foraging and homing task in aged rats.

  2010cites this paper
• Expression of the Anti-amyloidogenic Secretase ADAM10 Is Suppressed by Its 5′-Untranslated Region*

  2010cites this paper
• Correlations between soluble α/β forms of amyloid precursor protein and Aβ38, 40, and 42 in human cerebrospinal fluid.

  2010cites this paper
• Reduction of SorLA/LR11, a sorting protein limiting beta-amyloid production, in Alzheimer disease cerebrospinal fluid.

  2009cites this paper
• Plasma Angiotensin-Converting Enzyme in Alzheimer's Disease

  2009cites this paper
• Neuroprotective Secreted Amyloid Precursor Protein Acts by Disrupting Amyloid Precursor Protein Dimers*

  2009cites this paper
• ADAM-10 over-expression increases cortical synaptogenesis.

  2008cites this paper
• Etazolate, a neuroprotective drug linking GABAA receptor pharmacology to amyloid precursor protein processing

  2008cites this paper
• Seizure susceptibility and mortality in mice that over-express amyloid precursor protein.

  2008cites this paper
• The role of APP and its homologous proteins in synaptic function and plasticity

  2008influential citation
• Endogenous secreted amyloid precursor protein-alpha regulates hippocampal NMDA receptor function, long-term potentiation and spatial memory.

  2008cites this paper
• Flavonoids as Modulators of Amyloid Precursor Protein Metabolism and Alzheimer Disease Pathology

  2008cites this paper
• Evidence That Amyloid Pathology Progresses in a Neurotransmitter-Specific Manner

  2008cites this paper
• Aspects of beta-amyloid as a biomarker for Alzheimer's disease.

  2007cites this paper
• Secretases as Pharmacological Targets in Alzheimer's Disease

  2007cites this paper
• Dementia: The Significance of Cerebral Metabolic Disturbances in Alzheimer's Disease. Relation to Parkinson's Disease

  2007cites this paper
• Toward a reliable distinction between patients with mild cognitive impairment and Alzheimer-type dementia versus major depression.

  2006cites this paper
• sAPPalpha enhances the transdifferentiation of adult bone marrow progenitor cells to neuronal phenotypes.

  2006cites this paper
• (Make) stick and cut loose--disintegrin metalloproteases in development and disease.

  2006cites this paper
• Over-expression of two different forms of the alpha-secretase ADAM10 affects learning and memory in mice.

  2006cites this paper
• Altered synaptic function in Alzheimer's disease.

  2006cites this paper
• Roles of proteolysis and lipid rafts in the processing of the amyloid precursor protein and prion protein.

  2005cites this paper
• PAR-4 Is Involved in Regulation of β-Secretase Cleavage of the Alzheimer Amyloid Precursor Protein*

  2005cites this paper
• The non-amyloidogenic pathway: structure and function of alpha-secretases.

  2005cites this paper
• Deposition of amyloid fibrils promotes cell-surface accumulation of amyloid beta precursor protein.

  2004cites this paper
• A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model.

  2004cites this paper
• Frameshifted β-Amyloid Precursor Protein (APP+1) Is a Secretory Protein, and the Level of APP+1 in Cerebrospinal Fluid Is Linked to Alzheimer Pathology*

  2003cites this paper
• Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory.

  2003cites this paper
• Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients.

  2003cites this paper
• Phosphatidylinositol-3-kinase-Akt kinase and p42/p44 mitogen-activated protein kinases mediate neurotrophic and excitoprotective actions of a secreted form of amyloid precursor protein.

  2002cites this paper
• A STUDY OF β-SECRETASE CLEAVED ALZHEIMER AMYLOID PRECURSOR PROTEIN

  2002cites this paper